Melissa Brooks

机构：Dow University of Health Sciences, Blueprint Medicines (United States) · ORCID：0000-0002-8361-5291

发表论文 59 篇 · 总被引 843 次 · h-index 13

代表论文

• Perspectives Among Canadian Physicians on Factors Influencing Implementation of Mifepristone Medical Abortion: A National Qualitative Study (2020 · The Annals of Family Medicine · 被引 64)
• Trajectories of Dyspareunia From Pregnancy to 24 Months Postpartum (2022 · eScholarship (California Digital Library) · 被引 13)
• Sphingolipids and DHA Improve Cognitive Deficits in Aged Beagle Dogs (2022 · Frontiers in Veterinary Science · 被引 12)
• Comparing Self-Reported Pain During Intercourse and Pain During a Standardized Gynecological Exam at 12- and 24-Month Postpartum (2021 · The Journal of Sexual Medicine · 被引 5)
• A Novel Targeted Approach to Achieve Immune System Reset: CD45-Targeted Antibody Drug Conjugates Enable Autologous HSCT, Ameliorate Disease in Autoimmune Models, Potently Kill Human Immune Cells from Normal Donors and MS Patients, and Achieve Immune Depletion in Non-Human Primates (NHP) (2019 · Blood · 被引 5)
• First and Second-Trimester Surgical Abortion Providers and Services in 2019: Results From the Canadian Abortion Provider Survey (2023 · Journal of Obstetrics and Gynaecology Canada · 被引 4)